Let’s have real coffee with βιος-SBSCy at one of the most remarkable venues in Cyprus: the UCY Library!

Dear friends, members of the βιος-SBSCy,

Join us on Thursday 21st March at 17.00 hours in the LRC012 auditorium of the Library at the Univ. of Cyprus new campus (https://library.ucy.ac.cy/)

PRESENTATION BY:

Dr Athos Antoniades CEO and Head of Research at Stremble Ventures LTD

Title: “Scientific leadership in international projects and opportunities to collaborate with a Cyprus-based Biotech company”

Athos will showcase international projects in which his team is involved:

  • Comfortage, a 20m euro project (Horizon) of a consortium of 39 European partners, focusing on dementia and frailty;
  • Cardiocare, a 6m euro project (Horizon), studying cardiotoxicity induced by breast cancer treatments;
  • Myeloma- Risk, an ERC-PoC project were a novel approach to analyzing somatic mutations yields promising results in the prognosis of disease progression; 
  • CyprusGenome.org – A project led by Karaiskakio Foundation and CSHM on the genetic characterization of the Cypriot population; 
  • The Cyprus Intestinal Health Study – A clinical study that identified novel biomarkers for Colon Cancer in the Cypriot population. 

Athos will also present opportunities for research positions that will be becoming available.

Q&A and discussion

Coffee and refreshments will be served!

See you there (and please come on time)!

Follow the signs to the LRC012 auditorium from the entrance of the Library at the University of Cyprus !

Athos Antoniades completed his Ph.D. at the University of Cyprus and his undergraduate studies at SCSU, USA. He started his career at Glaxo Smith Kline, and has worked at the UCY (Computer Science department and the Medical School), the CING and Frederic University. His research focuses on Computational Biology and Bioinformatics. Athos established Stremble Ventures, a research company working in over 20 projects across Europe, USA and Asia. He also works as the National eHealth authority, leading the scientific coordination of Xt-EHR.

Stremble Ventures Ltd is built around a core interdisciplinary team of computer scientists, clinicians, bioinformaticians, statisticians and molecular biologists. It offers advanced analytics, bioinformatics and software engineering expertise for clinical trials, studies and medical research; its mission is to deliver innovative biotechnological and digital solutions in collaboration with an extensive global network of academic and industrial partners.

For non-members-why not join us? You can participate in a vibrant scientific community that you can call home!

Spread the love

Similar Posts

  • THE SBSCy SEMINAR SERIES 2022

    Ilias Georgakopoulos-Soares Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94158, USA -Ilias.GeorgakopoulosSoares@ucsf.edu Thursday 14th April, 2022, 5pm ‘Novel technologies for the detection of human disease’ Detection of disease, including cancer, at the earliest stage is of paramount importance for successful treatment. Even though liquid biopsies are an exciting and highly…

    Spread the love
  • THE SBSCy SEMINAR SERIES 2022

     Jorge Gutierrez-Merino  Senior Lecturer in Food MicrobiologyDepartment of Nutritional Sciences, School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, UK -j.gutierrez@surrey.ac.uk Thursday 19th May, 2022, 5pm  ‘Beneficial bacteria to combat inflammatory disorders and microbial infections’  Dr Gutierrez-Merino is a veterinarian and a molecular microbiologist with an extensive experience in the…

    Spread the love
  • THE SBSCy SEMINAR SERIES 2023

    Dario Dattilo Sapienza University, Rome, Italy Thursday 8 June 2023, 17.00 Deciphering the role of N6-Methyladenosine in the metabolism of circular RNAs in rhabdomyosarcoma Rescheduled! ABSTRACT Among RNA modifications, N6-Methyladenosine (m6A) is well known for its contribution to different processes controlling linear RNA metabolism, including splicing, stability, and translation of mRNAs. Conversely, the effects of…

    Spread the love
  • THE SBSCy SEMINAR SERIES 2022

    Brianna Bibel, PhD Cold Spring Harbor Laboratory Student Ambassador of IUBMB ‘Regulating the regulator: Phosphorylation-mediated regulation of the RNAi effector protein Argonaute’ FEBRUARY 3rd, 2022, 5pm Brianna “Bri” Bibel is a postgraduate student studying biochemistry and structural biology at Cold Spring Harbor Laboratory (CSHL)’s Graduate School of Biological Sciences in Cold Spring Harbor, New York. In the…

    Spread the love
  • THE SBSCy SEMINAR SERIES 2022

     Dimitrios K Papadopoulos1,2 1Human Genetics Unit (HGU), Institute of Genetics and Cancer (IGC), University of Edinburgh, EH4 2XU, UK 2Karolinska Institute, Department of Clinical Neuroscience, Centre for Molecular Medicine, 17176 Stockholm, Sweden Thursday 10th March, 2022, 5pm ‘‘In vivo study of transcriptional events by Fluorescence Correlation Spectroscopy’ Transcription factors (TFs) are chief regulators of gene…

    Spread the love
  • THE SBSCy SEMINAR SERIES 2024

    Ethan L Morgan University of Sussex Thursday 22 February 2024 5 pm Cyprus time Targeting protein ubiquitination to improve the response to chemoradiotherapy in HPV-positive cancer ABSTRACT Human papillomaviruses (HPV) are a major cause of cancer worldwide, and are the primary cause of almost all cervical cancers and a growing number of cancers of the…

    Spread the love